The Evolution of a Large Biobank at Mass General Brigham

被引:26
作者
Boutin, Natalie T. [1 ]
Schecter, Samantha B. [1 ]
Perez, Emma F. [2 ]
Tchamitchian, Natasha S. [1 ]
Cerretani, Xander R. [1 ]
Gainer, Vivian S. [3 ]
Lebo, Matthew S. [1 ,2 ]
Mahanta, Lisa M. [1 ]
Karlson, Elizabeth W. [1 ,2 ]
Smoller, Jordan W. [1 ,4 ]
机构
[1] Mass Gen Brigham Personalized Med, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Mass Gen Brigham Res Informat Sci & Comp, Boston, MA 02115 USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源
JOURNAL OF PERSONALIZED MEDICINE | 2022年 / 12卷 / 08期
关键词
Mass General Brigham Biobank; biobank; biorepository; personalized medicine; precision medicine; translational research; research operations; TOOL;
D O I
10.3390/jpm12081323
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The Mass General Brigham Biobank (formerly Partners HealthCare Biobank) is a large repository of biospecimens and data linked to extensive electronic health record data and survey data. Its objective is to support and enable translational research focused on genomic, environmental, biomarker and family history associations with disease phenotypes. The Biobank has enrolled more than 135,000 participants, generated genomic data on more than 65,000 of its participants, distributed approximately 153,000 biospecimens, and served close to 450 institutional studies with biospecimens or data. Although the Biobank has been successful, based on some measures of output, this has required substantial institutional investment. In addition, several challenges are ongoing, including: (1) developing a sustainable cost model that doesn't rely as heavily on institutional funding; (2) integrating Biobank operations into clinical workflows; and (3) building a research resource that is diverse and promotes equity in research. Here, we describe the evolution of the Biobank and highlight key lessons learned that may inform other efforts to build biobanking efforts in health system contexts.
引用
收藏
页数:18
相关论文
共 23 条
  • [1] Aragam KG, 2020, J AM COLL CARDIOL, V75, P2769, DOI 10.1016/j.jacc.2020.04.027
  • [2] Developing a Simplified Consent Form for Biobanking
    Beskow, Laura M.
    Friedman, Joelle Y.
    Hardy, N. Chantelle
    Lin, Li
    Weinfurt, Kevin P.
    [J]. PLOS ONE, 2010, 5 (10):
  • [3] Business Planning in Biobanking: How to Implement a Tool for Sustainability
    Ciaburri, Mirella
    Napolitano, Mariarosaria
    Bravo, Elena
    [J]. BIOPRESERVATION AND BIOBANKING, 2017, 15 (01) : 46 - 56
  • [4] Assessing and measuring financial sustainability model of the Spanish HIV HGM BioBank
    Consuegra Fernandez, Irene
    Garcia Merino, Isabel
    Angeles Munoz-Fernandez, Maria
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [5] Precision medicine in 2030-seven ways to transform healthcare
    Denny, Joshua C.
    Collins, Francis S.
    [J]. CELL, 2021, 184 (06) : 1415 - 1419
  • [6] Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR Study
    Dewey, Frederick E.
    Murray, Michael F.
    Overton, John D.
    Habegger, Lukas
    Leader, Joseph B.
    Fetterolf, Samantha N.
    O'Dushlaine, Colm
    Van Hout, Cristopher V.
    Staples, Jeffrey
    Gonzaga-Jauregui, Claudia
    Metpally, Raghu
    Pendergrass, Sarah A.
    Giovanni, Monica A.
    Kirchner, H. Lester
    Balasubramanian, Suganthi
    Abul-Husn, Noura S.
    Hartzel, Dustin N.
    Lavage, Daniel R.
    Kost, Korey A.
    Packer, Jonathan S.
    Lopez, Alexander E.
    Penn, John
    Mukherjee, Semanti
    Gosalia, Nehal
    Kanagaraj, Manoj
    Li, Alexander H.
    Mitnaul, Lyndon J.
    Adams, Lance J.
    Person, Thomas N.
    Praveen, Kavita
    Marcketta, Anthony
    Lebo, Matthew S.
    Austin-Tse, Christina A.
    Mason-Suares, Heather M.
    Bruse, Shannon
    Mellis, Scott
    Phillips, Robert
    Stahl, Neil
    Murphy, Andrew
    Economides, Aris
    Skelding, Kimberly A.
    Still, Christopher D.
    Elmore, James R.
    Borecki, Ingrid B.
    Yancopoulos, George D.
    Davis, F. Daniel
    Faucett, William A.
    Gottesman, Omri
    Ritchie, Marylyn D.
    Shuldiner, Alan R.
    [J]. SCIENCE, 2016, 354 (6319)
  • [7] Downey A.S, 2018, COMMITTEE RETURN IND
  • [8] ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
    Green, Robert C.
    Berg, Jonathan S.
    Grody, Wayne W.
    Kalia, Sarah S.
    Korf, Bruce R.
    Martin, Christa L.
    McGuire, Amy L.
    Nussbaum, Robert L.
    O'Daniel, Julianne M.
    Ormond, Kelly E.
    Rehm, Heidi L.
    Watson, Michael S.
    Williams, Marc S.
    Biesecker, Leslie G.
    [J]. GENETICS IN MEDICINE, 2013, 15 (07) : 565 - 574
  • [9] Characterizing biobank organizations in the US: results from a national survey
    Henderson, Gail E.
    Cadigan, R. Jean
    Edwards, Teresa P.
    Conlon, Ian
    Nelson, Anders G.
    Evans, James P.
    Davis, Arlene M.
    Zimmer, Catherine
    Weiner, Bryan J.
    [J]. GENOME MEDICINE, 2013, 5
  • [10] Prioritizing diversity in human genomics research
    Hindorff, Lucia A.
    Bonham, Vence L.
    Brody, Lawrence C.
    Ginoza, Margaret E. C.
    Hutter, Carolyn M.
    Manolio, Teri A.
    Green, Eric D.
    [J]. NATURE REVIEWS GENETICS, 2018, 19 (03) : 175 - +